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80 mg/ m2. Following chemotherapy, the patient was evaluated with a 
TCT which showed that her underskin mass had been disappeared, her 
mediastinal lymph nodes and pleural nodules had been regressed over 
50 %; also her complaints ended after chemotherapy. 
As it is known, in the treatment of malign mesothelioma, except the 
surgery in early stage patients, the studies about the chemotherapy are 
not so hopeful. This case is presented to show that pemetrexed (Alimta) 
can be an effective chemotherapy agent in mesothelioma treatment. 
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Background: Malignant mesothelioma is an extraordinarily chal-
lenging disease to treat; however, locoregional virotherapy may be 
applicable for this aggressive disease because of the accessibility by 
intrapleural and/or intratumoral virus delivery. We previously reported 
that an attenuated adenovirus OBP-301 (Telomelysin), in which the hu-
man telomerase reverse transcriptase (hTERT) promoter element drives 
expression of E1A and E1B genes linked with an internal ribosome 
entry site, could replicate in and causes selective lysis of human cancer 
cells. In the present study, we examined the antitumor effect of Telome-
lysin on human malignant mesothelioma cell lines in vitro and in vivo. 
Results: The XTT assay demonstrated that Telomelysin could ef-
ﬁciently kill four human mesothelioma cell lines H2052, H2452, H28, 
and 211H, all of which expressed the coxsackievirus and adenovirus 
receptor (CAR), in a dose-dependent manner. In vivo antitumor ef-
fect was also evaluated in an orthotopic pleural dissemination model. 
Intrathoracic administration of 2 x 108 plaque forming units (PFU) of 
Telomelysin markedly reduced the size (1 ± 1.8 mg vs. 190 ± 75 mg, p 
< 0.01) of H2452 tumors intrathoracically implanted into BALB/c-nu/
nu mice compared to mock-treated mice. 
Conclusions: These results suggest that locoregional administra-
tion of Telomelysin into the thoracic cavity may be efﬁcacious in the 
prevention and treatment of pleural dissemination of human malignant 
mesothelioma.
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Background: Although the association between asbestos exposure and 
the development of malignant pleural mesothelioma (MPM) is well 
recognized, the relationship between asbestos contents by ﬁber type 
and the risk of development for MPM remains unclear. In this study, 
we evaluated the asbestos contents by ﬁber type in the lung and the 
primary tumor of patients with resected MPM.
Methods: Asbestos ﬁber contents in the pulmonary parenchyma and 
tumor tissues were analyzed in 3 patients with MPM by transmission 
electron microscopy with energy-dispersive X-ray analysis using a 
low-temperature ashing procedure. The geometric mean content of total 
asbestos in the control subjects without history of asbestos exposure 
were used as reference, which was 1.83 x 106 ﬁbers / g dry lung. (Ref-
erence: Sakai K et al. Asbestos Concentration and Fiber Size in Lungs 
of the Urban Residents. Japanese Journal of Public Health, 1991; 38: 
762-770)
Results: Three patients were analyzed in this study, which were 
Case1: 50-year-old man, biphasic type, pT3N2M0 in the International 
Mesothelioma Interest Group staging system, Csae2: 54-year-old 
man, biphasic type, pT2N0M0 and Case 3: 56-year-old man, epithelial 
type, pT4N0M0. All patients had a history of asbestos exposure and 
underwent an extrapleural pneumonectomy with curative intent. As-
bestos ﬁbers were not detected in the tumor tissues in all patients. The 
geometric mean content of total asbestos in lung tissues were 1.8 ± 1.4 
(x 106 ﬁbers / g dry lung), 54.2 ± 33.1 and 6.5 ± 3.7 in the case1, case2 
and case3, respectively, which showed 1 time, 29.6 times and 3.6 times 
compared with that of the control subjects. The distributions of asbestos 
by ﬁber type in each patient were very different as following. 
 chrysotile crocidolite amosite others
Case1 71% 7% 7% 15%
Case2 49% 42% 7% 2%
Case3 11% 52% 7% 30%
Conclusions: Case1 had MPM without high level exposure of asbestos. 
On the other hand, case2 and case3 showed higher concentration of 
asbestos ﬁber in the lung tissue than control subject, which evidenced 
the high level exposure of asbestos. Those two patients also had a large 
proportion of crocidolite in the total asbestos ﬁbers, which might be 
associated with the development of MPM. To elucidate the relation be-
tween the pulmonary asbestos ﬁber contents by ﬁber type and develop-
ment of MPM, further investigation is considered necessary.
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Lungs represent one of the most common sites of secondary deposits of 
various primary tumors. However,incidence of endoluminal metastases 
is low(2-28%)because ﬁberoptic bronchoscopy is not performed rou-
tinely in all patients(pts) with pulmonary metastases.Also,these patients 
may also have low performance status and diagnosis is provided by 
other procedures.
During 2005 in our department 3724 bronchoscopies were done,mostly 
under suspicion on lung cancer.In 46(1.23%)endobronchial metastases 
were found.
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Male to female ratio was 17:29, mean age was 52.7 years (ranged from 
31 to 74 years). Relapse free time varied from 6 months to 5 years. All 
patients had abnormal radiographic ﬁnding. Radiography was done on 
routine control examination in 60% of patients, who had no symptoms. 
The most common primary malignancy was laryngeal carcinoma 
(22pts-47.8%), breast carcinoma (6pts-13%), adenocarcinoma of the 
colon (5pts-10.8%), thyroid gland carcinoma (5pts-10.8%) cervical 
carcinoma of the uterus (3pts-6.52%) and other, less common tumors 
(stomach, esophagus, prostate, tongue). Bronchoscopic ﬁnding revealed 
that endoluminal metastases were more common in right lung (in 31 
pts-67.4%). Most of the metastases were seen in upper lobe bronchi 
(52%). Biopsy was performed and pathohistological veriﬁcation was 
obtained in all patients. In more then 1/2 of the patients histologic type 
was squamocellular carcinoma.
We can conclude that ﬁberoptic bronchoscopy with biopsy is simple, 
cheap technique in diagnosis of endobronchial metastases. Histological 
veriﬁcation is 100% in centrally localized lesions.
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I would like to present the mediastinal adenosuamous cell carcinoma 
involved the left subclavian artery, left brachiocepharic vein, left recur-
rent nerve and left phrenic nerve. 
A 48-year-old male visited our institute with abnormal ﬁndings of 
left upper mediastinal on chest X ray. The left subclavian artery was 
involved with the tumor of 5.0 X 4.5 cm in diameter on chest CT scan. 
However, there were no left shoulder pain and lower arterial pressure 
of the left upper extremities than the right upper extremities. VATS 
(video-assisted thoracoscopic surgery) was performed for pathologi-
cal diagnosis, and the pathological diagnosis was adenosquamous cell 
carcinoma. PET (positron emission tomography) scan revealed the 
just uptake of the tumor site. So, we performed the mediastinal tumor 
resection and the combined resection of the left subclavian artery, the 
left brachiocepharic vein, left recurrent nerve and left phrenic nerve. 
The left subclavian artery reconstructed with Gelwaeve 8mm, and the 
left brachiocepharic vein reconstructed with ringed e-PTFE 10mm. The 
postoperative course was smooth and not eventful, he was discharge on 
the 10 days after operation.
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The aim of the study was to analyse clinical features and 1-yr survival 
rate of bronchial carcinoid patients diagnosed at the Institute of Lung 
Diseases and TB in Belgrade 1996-2006. 
The group consists of 58 pts (30 females and 28 males), the average 
age of 48 ys (17 - 75). 57 of them underwent operation: lobectomy in 
34pts (58.6.%), pneumonectomy in 11pts(19%), atypical resection in 
9pts (15.5%), bilobectomy in 3pts (5.2%). Hystologic ﬁnding of typical 
carcinoid tumor was in 39pts (67.2%), while atypical in 19pts (32.8%). 
Central tumor type was noted in 30pts(51.7%) and peripheral in 28pts 
(48.3%). CT scan showed that majority of peripheral tumors were 
3-3.5cmX4-4.5cm in diameter, with the exception of 1 case with the 
tumor size 8x7cm and 2 of size 6x5cm.
The most frequent symptoms were cough -30pts (51.7%), chest pain-
25pts (43.1%), dyspnoea -20pts (34.5%), haemoptysis-19pts (32.7%), 
fever-18pts(31.0%), weight loss-13pts (22.4%) and fatigue-12pts 
(20.7%). Majority of pts had disease symptoms lasting either 1 year 
and longer-25pts (43.1%) or less than 3 months -16pts (27.6%).
Five pts (8.6%) had associated neuroendocrine disorder or tumor either 
in the previous history or at the same time of bronchial carcinoid tumor 
diagnosis. Only one pt with Kushing Sy persisting after operation of 
gonadotropic adenoma of pituitary gland, has shown to have hormonal 
activity of the peripheral bronchial carcinoid tumor since this Sy re-
solved after lung operation.
The 1-year follow-up analysis shows 1-year survival rate of 86.2% 
(50pts): 8pts died within the ﬁrst year after diagnosis or operation. One 
pt died 6th day after operation due to fatal pulmonary embolism, and 
other 7 pts died due to metastatic disease relapse 
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Background: Insulin-like Growth Factor-1 (IGF-1) and its receptor 
(IGF-1R) are important for transformation and growth of malignant 
cells and for the prevention of apoptosis. IGF-1R is often over-ex-
pressed in malignant tumors and several oncogenes depend on intact 
IGF-1R to achieve their transforming activity. 
Recently, members of the cyclolignan family were identiﬁed as poten-
tial inhibitors of the IGF-1 receptor tyrosine kinase. Picropodophyllin 
(PPP), in particular, shows promise since it demonstrates selectivity for 
IGF-1R without inhibiting activity of the insulin receptor or other more 
distantly related receptors. There is, however, on ongoing debate if 
inhibition of microtubule assembly contributes to the cytotoxic effects 
of PPP as this is the major mechanism of action for its epimer podo-
phyllotoxin, PPT. Tumor cells of lung cancer also express IGF-1-re-
ceptors, but their role in the malignant phenotype is still not clear. The 
aim of this study was to investigate the role of IGF-1R in lung cancer 
and to evaluate its potential as a therapeutic target through use of PPP, 
a speciﬁc tyrosine kinase inhibitor of IGF-1R. We also investigated 
the relation between IGF-1 receptor status in cells and sensitivity to 
conventional and experimental chemotherapeutic agents, including PPT 
and other microtubule inhibiting agents.
